|
GPBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.510000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.881000E-01 |
| Normal-vs-Stage2 |
8.782000E-01 |
| Normal-vs-Stage3 |
5.446600E-01 |
| Normal-vs-Stage4 |
4.841600E-01 |
| Stage1-vs-Stage2 |
8.216800E-01 |
| Stage1-vs-Stage3 |
4.908000E-01 |
| Stage1-vs-Stage4 |
6.918600E-01 |
| Stage2-vs-Stage3 |
7.378000E-01 |
| Stage2-vs-Stage4 |
5.610600E-01 |
| Stage3-vs-Stage4 |
3.860000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.625600E-01 |
| Normal-vs-AfricanAmerican |
5.690400E-01 |
| Normal-vs-Asian |
5.980400E-01 |
| Caucasian-vs-AfricanAmerican |
6.397800E-01 |
| Caucasian-vs-Asian |
7.750600E-01 |
| AfricanAmerican-vs-Asian |
8.950000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.874600E-01 |
| Normal-vs-Female |
3.377000E-01 |
| Male-vs-Female |
2.487400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.047600E-01 |
| Normal-vs-Extreme_Weight |
9.319000E-01 |
| Normal-vs-Obese |
3.840000E-01 |
| Normal-vs-Extreme_Obese |
3.084400E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.629000E-01 |
| Normal_Weight-vs-Obese |
2.715600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.064400E-01 |
| Extreme_Weight-vs-Obese |
4.596600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.250850E-01 |
| Obese-vs-Extreme_Obese |
3.242300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.585400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.682390E-01 |
| Normal-vs-Age(61-80Yrs) |
4.416800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.886200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.252600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.209700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.899200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.841920E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.827200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.467200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.621040E-01 |
| Normal-VS-Type2 PRCC |
3.984100E-02 |
| Normal-VS-KIRP CIMP |
8.020800E-01 |
| Normal-VS-Unclassified PRCC |
7.919000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.553900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.474200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.177600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.726400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.091030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.810200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.076350E-01 |
| Normal-vs-N1 |
3.197800E-01 |
| Normal-vs-N2 |
3.019800E-01 |
| N0-vs-N1 |
2.398200E-02 |
| N0-vs-N2 |
1.551200E-01 |
| N1-vs-N2 |
8.649200E-01 |
|
|
